American scientists have developed a new injectable polymer called PolySTAT that stops severe bleeding. They say it could reach human trials in five years.

PolySTAT is not influenced by fibronolytic enzymes that break up fibrin strands to begin the healing process. While the enzymes are important in the long run, they slow clot formation, a dangerous activity during acute bleeding. Moreover, the material continues to work even when levels of a protein used to make fibrin drop.
In the initial study with rats, researchers achieved 100% success rate in stopping bleeding to an otherwise lethal injury to the femoral artery. For comparison, rats treated with natural protein albumin showed only 20% survival.
Source-Medindia